OSR Health, Inc.
OSRH- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001840425
No open-market purchases or sales by OSR Health, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $210.6K in total; no superinvestor holds it.
Other share classesOSRHW
Q3 2025 vs. Q2 2025
How the institutions holding OSR Health, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 87.9K | 225.1K | +137.2K (+156.1%) |
| Value | $120.7K | $120.4K | −$276 (−0.2%) |
New holders (4)
Institutions that held OSR Health, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 79,807 | $42.7K | 0.00% |
| Geode Capital Management, LLC | 55,587 | $29.7K | 0.00% |
| Vanguard Group Inc | 54,402 | $29.1K | 0.00% |
| XTX Topco Ltd | 23,571 | $12.6K | 0.00% |
Sold out (4)
Institutions that held OSR Health, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 35,464 | $48.6K |
| UBS Group AG | 24,407 | $33.7K |
| Virtu Financial LLC | 19,498 | $27.0K |
| Morgan Stanley | 57 | $79 |